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Abstract
Background: Congenital hypothyroidism from thyroid dysgenesis (CHTD) is predominantly a sporadic disease characterized
by defects in the differentiation, migration or growth of thyroid tissue. Of these defects, incomplete migration resulting in
ectopic thyroid tissue is the most common (up to 80%). Germinal mutations in the thyroid-related transcription factors
NKX2.1, FOXE1, PAX-8, and NKX2.5 have been identified in only 3% of patients with sporadic CHTD. Moreover, a survey of
monozygotic twins yielded a discordance rate of 92%, suggesting that somatic events, genetic or epigenetic, probably play
an important role in the etiology of CHTD.
Methodology/Principal Findings: To assess the role of somatic genetic or epigenetic processes in CHTD, we analyzed gene
expression, genome-wide methylation, and structural genome variations in normal versus ectopic thyroid tissue. In total,
1011 genes were more than two-fold induced or repressed. Expression array was validated by quantitative real-time RT-PCR
for 100 genes. After correction for differences in thyroid activation state, 19 genes were exclusively associated with thyroid
ectopy, among which genes involved in embryonic development (e.g. TXNIP) and in the Wnt pathway (e.g. SFRP2 and FRZB)
were observed. None of the thyroid related transcription factors (FOXE1, HHEX, NKX2.1, NKX2.5) showed decreased
expression, whereas PAX8 expression was associated with thyroid activation state. Finally, the expression profile was
independent of promoter and CpG island methylation and of structural genome variations.
Conclusions/Significance: This is the first integrative molecular analysis of ectopic thyroid tissue. Ectopic thyroids show a
differential gene expression compared to that of normal thyroids, although molecular basis could not be defined.
Replication of this pilot study on a larger cohort could lead to unraveling the elusive cause of defective thyroid migration
during embryogenesis.
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Introduction
Permanent primary hypothyroidism is the most common
congenital endocrine disorder. In up to 85% of cases, it results
from thyroid dysgenesis, a condition comprised of defects in the
differentiation, migration or growth of thyroid tissue. Of these
defects, incomplete migration resulting in ectopic thyroid tissue
(sub-lingual thyroid) is the most common (up to 80%). The
etiological diagnosis is established through thyroid scintigraphy
[1]. Ectopic thyroids are smaller (i.e. they lack the lateral lobes that
are characteristic of orthotopic thryroids) but are otherwise normal
(i.e. they have a normal follicular architecture and their capacity to
trap and organify iodine and to produce thyroid hormones and
thyroglobulin is intrinsically normal [2,3,4,5]). This suggests that
the hypothyroidism of subjects with thyroid ectopy is due to a
smaller amount of tissue (hypoplasia), which is a consequence of
the migration defect, and not to defects in differentiation or in
histological organization of the thyroid follicular cells.
Congenital hypothyroidism from thyroid dysgenesis (CHTD) is
a heterogeneous disease, which exists in familial (2%) and non-
familial (sporadic, 98%) forms [6]. Moreover, the results of a
survey of monozygotic twins yielded a discordance rate of 92%
[7], which together with the female predominance in CHTD [8]
suggest that complex non-Mendelian mechanisms underlie this
condition. On the other hand, environmental causes operating in
utero are unlikely because: (i) no temporal or seasonal trends for
CHTD have been observed [9] and (ii) MZ twins who are
discordant for CHTD have similar birth weight (G. Van Vliet,
personal communication). Germinal mutations in thyroid related
transcription factors NKX2.1, FOXE1, PAX-8, and NKX2.5
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and linkage analysis excluded these genes in some multiplex
families with CHTD, which is consistent with a complex genetic
contribution [10]. Together these findings indicate the involve-
ment of novel genes and pathways and underlines the importance
of somatic epigenetic or genetic events [11].
Combining data of gene expression, DNA methylation and
DNA copy number has led to the identification of novel genetic
regulators of cancer [12,13]. Consistent with this approach, we
aim to assess whether the transcriptome of ectopic thyroids is
shaped by somatic genomic or epigenomic variations (Figure 1).
Results
Expression array identified 1011 genes that are more
than two-fold induced or repressed
We used microarray analysis to compare the genome-wide
RNA expression profile of normal (orthotopic; n=1) versus
abnormal (ectopic; n=3) thyroid tissue. We identified 1833
differentially expressed genes, and a total of 1011 genes were
induced (n=522) or repressed (n=489) more than two-fold. The
forty genes with the highest differential expression are listed in
Table 1. To validate the differential expression identified by
microarray analysis, we performed quantitative real-time PCR
(qRTPCR) of 100 genes in ectopic thyroids compared with the
same commercial control (Ambion) used for the arrays; these 100
genes included highly differentially expressed genes and genes
known to play a role in the thyroid function. Overall, there was a
highly significant correlation between microarray and qRTPCR
(Pearson correlation coefficient of 0,86, p,2.2 e-16)(Figure S1).
Functional annotation clustering of the 1011
differentially expressed genes showed enrichment for
developmental processes
To assess whether the differentially expressed genes are related
to development and organogenesis, we classified the 1011
differentially expressed genes into gene ontology (GO) groups
using DAVID (Database for Annotation, Visualization and
Integrated Discovery) with medium classification stringency. Table
S1 shows the top three clusters for the 1011 differentially expressed
genes (more than two-fold induced or repressed) with enrichment
scores greater than 6 (i.e. p,1 E -06). Two of them are clusters of
genes enriched for developmental processes. We next clusterized
separately the induced (n=522) and the repressed (n=489) genes
using DAVID according to GO terms with high classification
stringency. The top five clusters of induced genes with enrichment
Figure 1. Breakdown of the experimental design and overview of the results.
doi:10.1371/journal.pone.0013420.g001
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TOP 20 induced genes
Entrez Gene Name Entrez Gene ID Array
a q-value (%)
b qRTPCR RQ value
c
LYZ 4069 5,99 0,0000 5,41
FOSB 2354 5,48 0,0000 5,62
IGJ 3512 5,44 0,0000
TRA@ 6955 5,23 0,7897
PAX8 7849 4,68 0,0000 2,55
CYBB 1536 4,62 0,0000
TRA@ 6955 4,60 0,0000
HLA-DQA1 3117 4,56 0,0000
CECR1 51816 4,49 0,0000
HLA-DQB1 3119 4,41 0,0000
EGR1 1958 4,29 0,0000
RNASE6 6039 3,98 0,0000
SFRP2 6423 3,91 0,0000 4,74
GPNMB 10457 3,87 0,0000 4,97
PABPC1 26986 3,85 0,0000
MS4A6A 64231 3,84 0,0000
KLF4 9314 3,74 0,7897
HADHA 3030 3,61 0,7897
FOS 2353 3,61 0,0000 4,46
IGHG4 3503 3,52 0,7897
TOP 20 repressed genes
Entrez Gene Name Entrez Gene ID Array
a q-value (%)
b qRTPCR RQ value
c
ABCA13 154664 26,06 0,0000 24,12
CKM 1158 25,86 0,0000 210,31
ACTA1 58 25,31 0,0000 25,06
C9orf70 84850 24,85 0,0000
CHGA 1113 24,83 0,0000 28,38
MYBPC1 4604 24,60 0,0000
ATP2A1 487 24,19 0,0000
TNNC2 7125 24,09 0,0000 24,64
IGSF1 3547 24,00 0,0000
EEF1A2 1917 23,87 1,9070
FLJ32115 121506 23,79 0,7897
PCSK2 5126 23,66 1,9070
RASD1 51655 23,53 2,7615 20,51
RARRES1 5918 23,52 1,9070
EDN3 1908 23,40 1,9070 21,83
PRKCE 5581 23,32 2,7615 1,98
GSTT1 2952 23,24 4,2100
FLJ11127 54491 23,20 3,2882
TCAP 8557 23,17 3,9587
LOC440696 3322 23,17 3,2882
aArray mean ratio are expressed in log2.
bQ-values (i.e. minimal false discovery rate) are expressed in percent, all P-values are less than 0.001.
cValidation with qRTPCR: RQ values are expressed in log2.
Bold characters indicate genes that are validated (13 of 14 tested) among these 40 genes.
doi:10.1371/journal.pone.0013420.t001
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development, vasculogenesis, the extracellular matrix, immune
system development and collagen whereas the top five clusters for
repressed genes with enrichment scores greater than 4 (i.e. p,1E-
04) show genes important for histone function, apoptosis,
chromatin function, organelle and contractile functions (Table
S2). Finally, the analysis of Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways with DAVID shows enrichment
(p,0.05) for eight pathways, among which three are associated
with cell-to-cell interaction (i.e. MAPK signaling pathway, focal
adhesion and cell communication) (Figure 2).
Additional validation against age-matched
hyperfunctioning thyroid tissue selects 19 genes whose
expression is related to thyroid ectopy and independent
of thyroid activation state
Level of activity (i.e. thyroid hormone production) and
consequently expression of genes involved in thyroid hormone
production is sensitive to thyroid stimulating hormone (TSH)
[14,15]. CHTD patients have high TSH at diagnosis, after which
the level oftheir TSHmayvary depending onthe compliance to the
treatment; or the TSH is high for years in cases of delayed
treatment, as in our case 1 (Table S3). To correct for differential
TSH-dependent activation of thyroid tissue, we extended the
qRTPCR analysis for the 100 validated genes to three hyperfunc-
tioning thyroid nodules (i.e. somatic activation of the TSH receptor)
that had arisen in otherwise normal (orthotopic) thyroids. Of the
100 genes, 19 showed consistently induction or repression when
compared to all types of controls (i.e. hyperfunctioning thyroid
nodules and the commercial control) (Table 1). The 81 remaining
genes showed divergent expression: i.e. they were either induced in
ectopic thyroid when compared to the commercial control but
repressed when compared to the three hyperfunctioning thyroid
nodules or vice versa (Table S4), suggesting that the expression of
those 81 genes was dependent of thyroid activation state.
Pathway analysis of the 19 selected genes showed
association with Wnt signalling pathway whereas the 81
excluded genes were enriched for thyroid
hormonogenesis and function
We then asked whether the use of two different types of control
was able to exclude genes that are dependent on thyroid activation
state and to identify genes associated exclusively with defective
migration of the thyroid. To consider the level of expression
(which is not possible with DAVID), we used the Ingenuity
Pathways Analysis software for GO annotation and pathway
analysis (IngenuityH Systems, www.ingenuity.com). The 19
selected genes (Table 2) were enriched for the Wnt pathway,
dendritic cell maturation pathway, and embryonic developmental
functions (for each enrichment scores greater than 1.5; p,0.02
and Benjamini-Hochberg multiple correction p,0.05). As expect-
ed, the 81 genes (Table S4) excluded because of divergent
expression are enriched for thyroid hormonogenesis and function:
thyroglobulin (TG), thyroid peroxidase (TPO), deiodinase type II
(DIO2), deiodinase type I (DIO1), dual oxidase 2 (DUOX2), paired
box gene 8 (PAX8), thyroid stimulating hormone receptor (TSHR)
and thyroid hormone responsive SPOT14 homolog (THRSP) (i.e
for GO term endocrine system disorders, the enrichment score is
2; p,0.01 and Benjamini-Hochberg multiple correction p,0.01).
To control for tissue quality, we also analyzed 10 unregulated
genes which are either well described thyroid-related transcription
factors (FOXE1, HHEX, NKX2.1, NKX2.5) [16] or genes
involved in the Wnt pathway (CTNNB1, GSK3B, CDH1, APC,
AXIN1, AXIN2) [17]. CTNNB1 and CDH1 showed divergent
expression; APC, AXIN1, AXIN2, FOXE1 and NKX2.1 showed
increases of convergent expression; and NKX2.5 expression was
massively increased when compared to orthotopic thyroids but
only slightly increased when compared to the commercial control,
which therefore might be considered as divergent. None of the
thyroid related transcription factors (FOXE1, HHEX, NKX2.1,
NKX2.5) showed decreased expression regardless of the control
used (Table 3).
Differential gene expression in ectopic thyroid is
independent of methylation
The next step was to assess whether somatic changes in DNA
methylation play a role in dysregulation of gene expression in
ectopic thyroids. Methylation profiling by methylated DNA
immunoprecipitation (MeDIP) and MeDIP-chip was performed
by hybridizing pairs of enriched methylated fraction (IP) and
normal fraction (IN) of genomic DNA from our three ectopic
thyroids and three controls orthotopic hyperfunctioning thyroid
nodules. The methylation profile was similar between the ectopic
and orthotopic thyroids: after multiple test correction, there was
no statistically significant difference (i.e. no region with a less
Figure 2. Expression array: gene pathway distribution in ectopic thyroid according to KEGG. The pathways are classified according to the
number of regulated genes (HEEBO array results). P-values of Fisher’s exact test for each KEGG pathways are listed to the right of the boxes. Dark gray,
induced genes; gray, repressed genes.
doi:10.1371/journal.pone.0013420.g002
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Consequently, no correlation was found between the differential
expression in ectopic thyroids and the global methylation profile.
Differential gene expression in ectopic thyroid is
independent of thyroid-specific CNVs
To assess whether thyroid-specific (i.e. absent in matched
leucocytes) CNVs shape gene expression in ectopic thyroids, we
used array comparative genomic hybridization (aCGH) of the
ectopic thyroid DNA with matched leucocytes. By analyzing data
as described in Materials and Methods, we found four thyroid-specific
CNVs (three validated by qPCR), which are reported variants as
reported in the Database for Genomic Variants (http://projects.
tcga.ca/variation) (Table S5). No correlation was found between
thyroid-specific CNVs and differentially expressed genes in ectopic
thyroids.
Table 2. Validated genes (n=19) with convergent induced (n=16) and repressed (n=3) expression in ectopic thyroid tissue (i.e.
independent of the activation state and dependent on the localization of the thyroid tissue).
Entrez Gene Name Enterz Gene ID Array
a
qRTPCR vs normal
thyroid
a
qRTPCR vs hot
nodules
a Taq Man Assay ID for qRTPCR
SFRP2 6423 3,91 4,74 5,48 Hs00293258_m1
TBX1 6899 1,52 3,21 1,57 Hs00271949_m1
GPNMB 10457 3,87 4,97 1,45 Hs01095669_m1
DUSP6 1848 1,98 3,09 1,32 Hs01044001_m1
FRZB 2487 0,83 1,83 1,24 Hs00173503_m1
COL1A1 1277 2,71 5,93 1,10 Hs00164004_m1
FGL2 10875 2,46 4,22 1,00 Hs00173847_m1
LYZ 4069 5,99 5,41 0,94 Hs00426231_m1
COL3A1 1281 3,39 5,12 0,89 Hs00164103_m1
TYROBP 7305 2,25 3,62 0,76 Hs00182426_m1
TNFAIP2 7127 3,45 4,63 0,68 Hs00196800_m1
BGN 633 1,09 3,14 0,63 Hs00959143_m1
PBX4 80714 1,83 3,67 0,58 Hs00257935_m1
PLCXD1 55344 1,71 2,83 0,58 Hs00383111_m1
CPEB4 80315 1,28 2,6 0,54 Hs00270923_s1
MKRN1 23608 2,63 1,18 0,53 Hs00831972_s1
TXNIP 10628 22,81 21,78 20,51 Hs01006900_g1
ABCA13 154664 26,06 24,06 20,71 Hs00541549_m1
ENO3 2027 21,99 20,86 21,15 Hs00266551_m1
aArray mean ratio and qRTPCR RQ are expressed in log2.
Bold characters indicate genes that are directly associated with the Wnt pathways (canonical and non-canonical).
Italic characters indicate genes that are regulators of the Wnt/beta-Catenin pathway [32].
doi:10.1371/journal.pone.0013420.t002
Table 3. Quantitative RTPCR for 10 controls.
Entrez Gene
Name
Entrez
Gene ID
RQ of qRTPCR vs
normal thyroid
a
RQ of qRTPCR vs
hot nodules
a
Taq Man Assay ID
for qRTPCR
APC 324 2,31 0,13 Hs01568269_m1
AXIN1 8312 1,39 0,2 Hs00394718_m1
AXIN2 8313 2,05 0,62 Hs01063168_m1
CTNNB1 1499 1,35 20,53 Hs00355045_m1
CDH1 999 2,07 20,35 Hs00170423_m1
FOXE1 2304 2,58 0,47 Hs00538731_s1
GSK3B 2932 2,1 0 Hs00275656_m1
HHEX 3087 1,62 0,05 Hs00242160_m1
NKX2.1 16002 1,43 0,36 Hs00163037_m1
NKX2.5 1482 0,53 6,93 Hs00231763_m1
aArray mean ratio and qRTPCR RQ are expressed in log2.
doi:10.1371/journal.pone.0013420.t003
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Generally, CHTD is sporadic and shows discordance between
MZ twins [7]. Somatic genetic or epigenetic events might
therefore have a role in the etiology of this condition. The
objective of this study was to assess whether somatic molecular
events account for the failure of migration of ectopic thyroids.
Therefore, we conducted the first integrative analysis of tran-
scriptome, DNA methylation and structural variants (CNV) in
ectopic thyroids.
We found altered expression in genes and pathways that might
play a significant role in abnormal thyroid development (e.g. Wnt
signaling pathway). Interestingly, none of the thyroid related
transcription factors (FOXE1, HHEX, NKX2.1, NKX2.5)
showed decreased expression, whereas PAX8 expression was
associated with thyroid activation state. This is a direct indication
that the expression of these known candidate genes is at least
neutral in ectopic thyroid and is consistent with the observation
that the coding sequences for FOXE1, NKX2.1 and PAX8 were
normal in case #1 [5].
Four pathways identified by analysing the results of expression
arrays (i.e. focal adhesion, antigen processing and presentation,
cell communication, cell adhesion molecules and Type I diabetes)
have been identified independently in hyperfunctioning thyroid
nodules [18]. However, our results identify mostly induced genes
in these pathways (Figure 1) whereas repression of these genes was
observed in the aforementioned study [18]. To obtain, in ectopic
thyroid, an opposite expression pattern when compared to that of
orthotopic hyperfunctional thyroid (i.e. thyroid with somatic TSH
receptor activating mutation) is plausible, but it underlines also the
need to consider the differential activation of the TSH-receptor
signaling pathways in our samples. Consequently, we have
excluded 81 validated genes for which expression was associated
with TSH-driven thyroidal activity.
The 19 selected genes whose expression was dependent on
thyroid location (i.e. ectopy) were enriched for pathways involved
in cellular movement (i.e. Wnt pathway and dendritic cell
maturation pathway). This association has biological plausibility
especially for the Wnt pathway. First, non-canonical Wnt pathway
is crucial for cell migration [19] and development of organs of
endodermal origin (e.g. intestine, lung, pancreas) [20]. There is
indirect evidence for the involvement of the non-canonical Wnt
pathway in the developing thyroid in mice [21], even though the
canonical Wnt/beta-catenin pathway seems to be inactive during
thyroid development in mice and humans [21,22]. Second, as Wnt
signaling is implicated in development and cancer [23], to find an
association between Wnt pathway and thyroid ectopy (i.e. failure
of proper thyroid migration during development) makes biolog-
ically sense. Indeed, SFRPs have been associated with embryonic
patterning [24], inhibition of meduloblastoma cell proliferation
[25] and inhibition of glioma cell motility [26]. Inhibition of the
Wnt pathway by Wnt5-a has also been shown to supress tumor
activity in thyroid carcinoma [27].
This study has several limitations. First, the expression profiles
in tissue collected and analyzed postnatally may not reflect
embryonic expression. Consequently, whether the differences we
observed are causes or consequences of the ectopic location of the
thyroid remains to be tested. Second, even though clusters of genes
involved in histone and chromatin function have repressed
expression in ectopic thyroids, we have not formally excluded a
role of differential histone methylation or acetylation on
differential gene expression in ectopic thyroids. Third, the arrays
used for the CNVs and methylome analyses have their own limits
in definition and genome coverage. Lastly, the sample number is
small but our preliminary findings justify testing a larger number
of samples.
This study identifies interesting candidate pathways that may
play important roles in the migration of the embryonic thyroid and
provides a prototype approach for the study of congenital
disorders difficult to explain by classical genetics.
Methods
Ethic Statement
This study was approved by the Ethics Committee of the CHU
Sainte-Justine (ERB number 94). All the parents gave written
informed consent.
Patients and Tissue Collection
We obtained flash-frozen samples of ectopic thyroid tissue
removed from 3 girls aged 8, 10 and 15 yr, because it caused local
symptoms (i.e. dysphagia). For controls, we used (i) thyroid tissue
from 2 girls (aged 15 and 16 yr) and 1 boy (aged 4 yr) who were
operated for a single hyperfunctioning thyroid nodule that had
arisen in an orthotopic thyroid and (ii) commercially available
RNA from normal thyroid when appropriate (Table S5).
Functional clusters and pathways analysis
We submitted the 1011 differentially expressed genes into gene
ontology (GO) groups using the DAVID database (http://david.
abcc.ncifcrf.gov) for cluster analysis according to Gene Ontology
(GO) terms with medium or high classification stringency. To
provide a refined analysis, the 100 validated gene were analyzed
through Ingenuity Pathways Analysis (IPA; http:www.ingenuity.
com), a software that also considers the level of gene expression.
With either DAVID or IPA, the proportion of each gene in the
submitted list is compared with the one in the whole genome to
compute the P value of the Fisher’s test, the enrichment scores (i.e.
geometric mean of the inverse log of each P value) and the
Benjamini-Hochberg multiple correction P value.
Expression Arrays
After surgical resection, the samples were immediately frozen in
liquid nitrogen and stored at 270 Celsius until use. Total RNA
was extracted as per manufacturer recommendations using the
QIAzol kit (QIAGEN Inc., Ontario, Canada). RNA was DNase-
treated to minimize DNA contamination. RNA quantity was
measured by ND-1000 (Nanodrop, Wilmington, DE, USA). RNA
quality was assessed by electropherograms on the Agilent 2100
Bioanalyzer. Microarray hybridization was performed on three
different ectopic thyroids (two in duplicate, one in quadruplicate)
and compared to RNA of thyroid tissue from a Caucasian female,
age 68 y with gall bladder cancer (Ambion, #AM6872). Double-
stranded cDNA was synthesized from 1 mg of total RNA, followed
by production of antisense RNA containing the modified
nucleotide 5-(3-aminoallyl)-UTP using the Amino Allyl Messa-
geAmp
TM II aRNA Amplification kit (Ambion, Texas, USA).
After labeling with Cy3 or Cy5 (GE Healthcare Bio-Sciences, New
Jersey, USA), sample pairs were hybridized onto Human Exonic
Evidence Based Oligonucleotide HEEBO slides (Stanford Func-
tional Genomics Facility, CA, USA). The oligonucleotide set
consists of 44544 70-mer probes that were designed using a
transcriptome-based annotation of exonic structure for genomic
loci. Hybridizations were replicated with dye swap. Slides were
scanned using a Molecular Devices 4000B Laser scanner and
expression levels were quantified using GenePix Pro 6.1 image
analysis software (Axon Instruments, CA, USA). Image acquisi-
tions were performed with automatic photomultiplier gains (PMT)
Genes and Thyroid Migration
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visual and software-guided flags, as were spots with a signal/
background fluorescence ratio less than 2. The fluorescence values
were imported into Acuity 4.0 software package (Molecular
Devices, Union City, CA, USA). A non-linear locally weighted
scatter plot (Lowess) normalization method applied to each
individual block (print-tip option) was carried out using Acuity
4.0 software package (Molecular Devices, Union City, CA,
USA)[28]. The identification of genes with significant differences
in expression levels was performed using the significance analysis
of microarray method (SAM one class) [29]. SAM estimates the
percentage of genes identified by chance, the false discovery rate
(FDR). We assessed the statistical significance of the differential
expression of genes by computing a q-value (i.e. minimum FDR)
for each gene (Table 1). Genes were considered to be differentially
expressed when the absolute normalized fold change between
ectopic thyroids and control was determined to be greater than 2.0
or less than 0.5 in at least one pair of the hybridized arrays. Full
access to the primary array data is available on the GEO web site
(http://www.ncbi.nlm.nih.gov/projects/geo/) under accession
number GSE16804.
Quantitative Real-Time RT-PCR
Validation of the expression levels of 100 genes of interest was
carried out using TaqMan low density array (TLDA) technology
(Applied Biosystems, Ontario, Canada). Probes and primers have
been selected with the publically available software http://www5.
appliedbiosystems.com/tools/ and can be retrieved by using the
assay ID reported in Tables 2, 3 and S4. The expression levels
were normalized to the expression level of the 18S rRNA. Induced
(n=49) and repressed (n=51) genes were selected from the 1011
differentially regulated genes found in the HEEBO expression
microarray analysis. Total RNAs from thyroids were first treated
with the DNA-free kit to remove residual contamination of
genomic DNA (Ambion Inc.). DNA-free total RNA (175 ng) was
subjected to reverse transcription using High-Capacity cDNA
Reverse Transcription Kits (Applied Biosystems). An aliquot of the
cDNA was mixed to TaqManH Gene Expression Master Mix,
loaded on the TLDA plates then centrifuged for distribution of the
material in the 384 wells. Gene target amplifications were
performed in triplicate using the 7900HT Real-Time PCR System
(Applied Biosystems). Sequence Detection System software version
2.2.2 (Applied Biosystems) was used for comparative gene
expression analysis using the A ¨Ct method. In a first analysis,
expression levels found in the normal orthotopic thyroid from
Ambion were compared to the mRNA levels present in the ectopic
thyroids. Expression levels in the hot nodules were then compared
to the levels found in the ectopic thyroids. For analysis, the cut-off
log2 value was 0.5. Then, to compare the results of the quantitative
real-time RT-PCR with those of expression arrays, Pearson
correlation was calculated with the free statistical software R [30].
Methylation Profiling by Methylated DNA
Immunoprecipitation (MeDIP) and MeDIP-chip
The MeDIP-chip was performed using pairs of enriched
methylated fraction (IP) and normal fraction (IN) of genomic
DNA from our three ectopic thyroids and three controls (i.e.
hyperfunctioning thyroid nodules). The methylated fraction of
genomic DNA was enriched using the methylated DNA
immunoprecipitation (MeDIP) assay [31] and interrogated on
human Promoter plus CpG Island Tiling Arrays with a ChIP
design for CpG islands and promoter regions (n=28,226) from
HG18 using 385,020 Probes selected from CGH probe bank with
a median spacing of 101bp (Roche NimbleGen, Madison, WI).
Briefly, 4 mg MseI digested genomic DNA was immunoprecipitat-
ed with monoclonal mouse anti 5-methylcytidine antibody (New
England Biolab, Pickering, Ontario and Abcam Inc.Cambridge,
MA 02139). After washes and purification steps, immunoprecip-
itated material and a sample of input DNA were amplified using
GenomePlex Complete Whole Genome Amplification (WGA) kit
(Sigma-Aldrich, Saint Louis, Missouri 63103 USA). The resulting
products (4 mg) were labeled, cohybridized and scanned by the
NimbleGen Customer Service (Roche NimbleGen, Madison, WI).
For each sample, NimbleScan detects peaks by searching for at
least two probes above a P-value cutoff (2log10) of 2 and peaks
within 500bp are merged (gff files on GEO web site). Then, peak
data were analyzed to compare the methylation profile between
ectopic thyroids and orthotopic thyroids using the Loess
normalized log2 (ChIP/input) ratios with the one-way ANOVA
tool of the Partek Genomics Suite (PGS) software. A FDR less than
0.1 was considered as significant. Full access to the primary array
data is available on the GEO web site (http://www.ncbi.nlm.nih.
gov/projects/geo/) under accession number GSE17581.
Array Comparative Genomic Hybridization and validation
with quantitative real-time PCR
Array comparative genomic hybridization (aCGH) was per-
formed using pairs of thyroid tissues and leucocytes from the three
ectopic thyroids. We used the Nimblegen X1 HG18 whole
genome CGH design (version 2). The 385,815 probes are
distributed across the genome with a median spacing of
7073 bp. Probes are 60-mers, with a Tm target of 80 degrees.
Labeling, hybridization, washing and scanning was performed by
the NimbleGen Customer Service (Roche NimbleGen, Madison,
WI). After normalization, the log2 (test/reference) signals were
analyzed using a circular binary segmentation algorithm
(segMNT) with the PGS Software to identify somatically acquired
segmental copy number changes. To call a copy number change,
segMNT required a segment to span a minimum of 5 consecutive
probes with a p-value threshold of 0.001 and a signal to noise ratio
of 0.3. Then, reported regions were set at segMNT log2 ratio
below 0.3 or above 0.2 in all three samples with a p-value
threshold of 0.01. Full access to the primary array data is available
on the GEO web site (http://www.ncbi.nlm.nih.gov/projects/
geo/) under accession number GSE17463. Validation of the
aCGH with quantitative real-time PCR was performed with the
TaqMan technology. Identified CNVs were validated using
TaqMan Gene Copy Number Assays from ABI. Probes and
primers have been selected with the public available software
(http://www5.appliedbiosystems.com/tools/cnv/) and can be
retrieved by using the assay ID reported in Table S5.
Supporting Information
Figure S1 Reliability of the HEEBO expression array was
confirmed by calculating the Pearson correlation coefficient
(r=0,86; P,2.2 e-16, n=100 genes; ectopic thyroid (n=3) vs
normal thyroid - Ambion, #AM6872) between microarray and
qRT-PCR results. Results are expresed in log2 ratio.
Found at: doi:10.1371/journal.pone.0013420.s001 (0.01 MB
PDF)
Table S1 The top three clusters for the 1011 differentially
expressed genes (more than two-fold induced or repressed).
Found at: doi:10.1371/journal.pone.0013420.s002 (1.92 MB
TIF)
Table S2 Clusters for the induced (n=522) and repressed
(n=489) genes.
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PDF)
Table S3 Source of patients derived thyroid tissues.
Found at: doi:10.1371/journal.pone.0013420.s004 (0.02 MB
PDF)
Table S4 Validated genes (n=81) with divergent expression in
ectopic thyroid tissue (i.e. dependent on the activation state and
independent of the localization of the thyroid tissue).
Found at: doi:10.1371/journal.pone.0013420.s005 (0.07 MB
PDF)
Table S5 Thyroid specific CNVs found in ectopic tissues.
Found at: doi:10.1371/journal.pone.0013420.s006 (0.05 MB
PDF)
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